Top

Published in:

01-09-2017 | Original Article

Screening for symptom burden and supportive needs of patients with glioblastoma and brain metastases and their caregivers in relation to their use of specialized palliative care

Authors: Bettina Seekatz, Matthias Lukasczik, Mario Löhr, Katja Ehrmann, Michael Schuler, Almuth F. Keßler, Silke Neuderth, Ralf-Ingo Ernestus, Birgitt van Oorschot

Published in: Supportive Care in Cancer | Issue 9/2017

Abstract

Purpose

Patients with brain tumors have a high symptom burden and multiple supportive needs. Needs of caregivers are often unattended. This study aims to determine screening-based symptom burden and supportive needs of patients and caregivers with regard to the use of specialized palliative care (SPC).

Methods

Seventy-nine patients with glioblastoma and brain metastases and 46 caregivers were screened with standardized questionnaires following diagnosis and 2 months later. The screening assessed symptom burden, quality of life (QoL), distress, and supportive needs.

Results

The most relevant symptoms were drowsiness, tiredness, and low well-being (53–58%). The most prevalent patient supportive needs were the need for information about available resources, the illness, and possible lifestyle changes (50–56%). The most prevalent caregiver needs were information about the illness, lifestyle changes, and about available resources (56–74%). Patients who received SCP and their caregivers had higher symptom burden and supportive needs than those without SPC. They reported moderate improvement in pain, distress, and QoL, while patients without SPC also improved their QoL, but had small to moderate deteriorations in pain, drowsiness, nauseas, well-being, and other problems. Distress of caregivers with SPC improved with moderate to large effect sizes but still was on a high level and remained stable for those without SPC.

Conclusions

Symptom burden and supportive needs were high, but even more caregivers than patients expressed high distress and supportive needs. SPC appears to reach the target group, both patients and caregivers with elevated symptom burden. Targeted interventions are needed to improve tiredness and drowsiness.

Altman DG, Machin D, Bryant T, Gardener MJ (2000) Statistics with confidence. Confidence intervals and statistical guidelines. BMJ Books, Bristol

Bakitas M, Lyons KD, Hegel MT, Balan S, Brokaw FC, Seville J, Hull JG, Li Z, Tosteson TD, Byock IR, Ahles TA (2009) Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA 302(7):741–749. doi:10.1001/jama.2009.1198 CrossRefPubMedPubMedCentral

Blais MC, St-Hilaire A, Fillion L, De Serres M, Tremblay A (2014) What to do with screening for distress scores? Integrating descriptive data into clinical practice. Palliat Support Care 12(1):25–38. doi:10.1017/S1478951513000059 CrossRefPubMed

Boele FW, Uden-Kraan CF, Hilverda K, Reijneveld JC, Cleijne W, Klein M, Verdonck-de Leeuw IM (2016) Attitudes and preferences toward monitoring symptoms, distress, and quality of life in glioma patients and their informal caregivers. Support Care Cancer 24(7):3011–3022. doi:10.1007/s00520-016-3112-7 PubMedPubMedCentral

Boyes A, Girgis A, Lecathelinais C (2009) Brief assessment of adult cancer patients’ perceived needs: development and validation of the 34-item Supportive Care Needs Survey (SCNS-SF34). J Eval Clin Pract 15(4):602–606. doi:10.1111/j.1365-2753.2008.01057.x CrossRefPubMed

Brandes K, Linn AJ, Butow PN, van Weert JC (2015) The characteristics and effectiveness of question prompt list interventions in oncology: a systematic review of the literature. Psychooncology 24(3):245–252. doi:10.1002/pon.3637 CrossRefPubMed

Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7(2):6–9PubMed

Bultz BD, Groff SL, Fitch M and Screening for Distress Toolkit Working Group (2009) Canadian problem checklist. In The guide to implementing screening for distress, the 6th vital sign, part A: background, recommendations, and implementation. Retrieved from http://www.cancerview.ca/idc/groups/public/documents/webcontent/guide_implement_sfd.pdf. Accessed 07 Nov 2016

Bultz BD, Groff SL, Fitch M, Blais MC, Howes J, Levy K, Mayer C (2011) Implementing screening for distress, the 6th vital sign: a Canadian strategy for changing practice. Psycho-Oncology 20(5):463–469. doi:10.1002/pon.1932 CrossRefPubMed

10.

Cahill J, LoBiondo-Wood G, Bergstrom N, Armstrong T (2012) Brain tumor symptoms as antecedents to uncertainty: an integrative review. J Nurs Scholarsh 44(2):145–155. doi:10.1111/j.1547-5069.2012.01445.x CrossRefPubMed

11.

Campion FX, Larson LR, Kadlubek PJ, Earle CC, Neuss MN (2011) Advancing performance measurement in oncology: quality oncology practice initiative participation and quality outcomes. J Oncol Pract 7(3 Suppl):31s–35s. doi:10.1200/JOP.2011.000313 CrossRefPubMedPubMedCentral

12.

Chang VT, Hwang SS, Feuerman M (2000) Validation of the Edmonton Symptom Assessment Scale. Cancer 88(9):2164–2171. doi:10.1002/(SICI)1097-0142(20000501)88:9<2164::AID-CNCR24>3.0.CO;2-5 CrossRefPubMed

13.

Dalgaard KM, Bergenholtz H, Nielsen ME, Timm H (2014) Early integration of palliative care in hospitals: a systematic review on methods, barriers, and outcome. Palliative and Supportive Care 12(06):495–513. doi:10.1017/S1478951513001338 CrossRefPubMed

14.

Du S, Hu L, Dong J, Xu G, Jin S, Zhang H, Yin H (2015) Patient education programs for cancer-related fatigue: a systematic review. Patient Educ Couns 98(11):1308–1319. doi:10.1016/j.pec.2015.05.003 CrossRefPubMed

15.

Ford E, Catt S, Chalmers A, Fallowfield L (2012) Systematic review of supportive care needs in patients with primary malignant brain tumors. Neuro-Oncology 14(4):392–404. doi:10.1093/neuonc/nor229 CrossRefPubMedPubMedCentral

16.

Groenvold M, Petersen MA, Aaronson NK, Arraras JI, Blazeby JM, Bottomley A, Fayers PM, de Graeff A, Hammerlid E, Kaasa S, Sprangers MA, Bjorner JB, EORTC Quality of Life Group (2006) The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. Eur J Cancer 42(1):55–64. doi:10.1016/j.ejca.2005.06.022 CrossRefPubMed

17.

Grov EK, Dahl AA, Moum T, Fosså SD (2005) Anxiety, depression, and quality of life in caregivers of patients with cancer in late palliative phase. Ann Oncol 16(7):1185–1191. doi:10.1093/annonc/mdi210 CrossRefPubMed

18.

Hui D, Shamieh O, Paiva CE, Perez-Cruz PE, Kwon JH, Muckaden MA, Park M, Yennu S, Kang JH, Bruera E (2015) Minimal clinically important differences in the Edmonton Symptom Assessment Scale in cancer patients: a prospective, multicenter study. Cancer 121(17):3027–3035. doi:10.1002/cncr.29437 CrossRefPubMedPubMedCentral

19.

Karnofsky DA, Abelman WH, Craver F, Burchenal JH (1948) The use of nitrogen mustards in the palliative treatment of cancer. Cancer 1:634–6456. doi:10.1002/1097-0142(194811)1:4<634::AID-CNCR2820010410>3.0.CO;2-L CrossRef

20.

Kelly B, McClement S, Chochinov HM (2006) Measurement of psychological distress in palliative care. Palliat Med 20(8):779–789. doi:10.1177/0269216306072347 CrossRefPubMed

21.

German guideline program in oncology GGPO Deutsche Krebsgesellschaft, AWMF (2015) Evidenced-based guideline: palliative care for patients with incurable cancer, short version 1. 1. AWMF-Registration number: 128/001OL, http://www.awmf.org/fileadmin/user_upload/Leitlinien/128_D_Ges_fuer_Palliativmedizin/128-001OLke_S3_palliative_care_incurable_cancer_2016-03.pdf. Accessed 07 Nov 2016

22.

Lin E, Rosenthal MA, Le BH, Eastman P (2012) Neuro-oncology and palliative care: a challenging interface. Neuro-Oncology 14(suppl 4):iv3–iv7. doi:10.1093/neuonc/nos209 CrossRefPubMedPubMedCentral

23.

Li M, Macedo A, Crawford S, Bagha S, Leung YW, Zimmermann C, Fitzgerald B, Wyatt M, Stuart-McEwan T, Rodin G (2016) Easier said than done: keys to successful implementation of the Distress Assessment and Response Tool (DART) Program. J Oncol Pract 12(5):e513–e526. doi:10.1200/JOP.2015.010066 CrossRefPubMed

24.

Lukasczik M, Seekatz B, Radina S, Häckel A, Neuderth S, van Oorschot B (2016) Computergestütztes Screening auf Palliativbedarf bei onkologischen Patienten [Computer-assisted screening for palliative needs of cancer patients]. Onkologe 22(1):56–60. doi:10.1007/s00761-015-3075-1 CrossRef

25.

Marcucci FC, Cabrera MC, Perilla AB, Brun MM, de Barros EM, Martins VM, Rosenberg JP, Yates P (2016) Identification and characteristics of patients with palliative care needs in Brazilian primary care. BMC Palliative 15:51. doi:10.1186/s12904-016-0125-4 CrossRef

26.

Mehnert A, Muller D, Lehmann C, Koch U (2006) Die deutsche Version des NCCN Distress Thermometers [The German version of the NCCN Distress Thermometer]. Z Psychiatr Psychol Psychother 54(3):213–223. doi:10.1024/1661-4747.54.3.213

27.

Mercadente S, Adile C, Caruselli A, Ferrera P, Costanzi A, Marchetti P, Casuccio A (2016) The Palliative-Supportive Care Unit in a Comprehensive Cancer Center as Crossroad for Patients’ Oncological Pathway. PLoS One 11(6):e0157300. doi:10.1371/journal.pone.0157300 CrossRef

28.

Mitchell AJ (2013) Screening for cancer-related distress: when is implementation successful and when is it unsuccessful? Acta Oncol 52(2):216–224. doi:10.3109/0284186X.2012.745949 CrossRefPubMed

29.

Ostgathe C, Gaertner J, Kotterba M, Klein S, Lindena G, Nauck F, Voltz R (2010) Differential palliative care issues in patients with primary and secondary brain tumours. Support Care Cancer 18(9):1157–1163. doi:10.1007/s00520-009-0735-y CrossRefPubMed

30.

Paiva CE, Manfredini LL, Paiva BSR, Hui D, Bruera E (2015) The Brazilian version of the Edmonton Symptom Assessment System (ESAS) is a feasible, valid and reliable instrument for the measurement of symptoms in advanced cancer patients. PLoS One 10(7):e0132073. doi:10.1371/journal.pone.0132073 CrossRefPubMedPubMedCentral

31.

Puts MTE, Papoutsis A, Springall E, Tourangeau AE (2012) A systematic review of unmet needs of newly diagnosed older cancer patients undergoing active cancer treatment. Support Care Cancer 20(7):1377–1394. doi:10.1007/s00520-012-1450-7 CrossRefPubMed

32.

Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC (1998) Rapid screening for psychologic distress in men with prostate carcinoma. Cancer 82(10):1904–1908. doi:10.1002/(SICI)1097-0142(19980515)82:10<1904::AID-CNCR13>3.0.CO;2-X CrossRefPubMed

33.

Richardson LA, Jones GW (2009) A review of the reliability and validity of the Edmonton Symptom Assessment System. Curr Oncol 16(1):53–64. doi:10.3747/co.v16i1.261

34.

Schubart JR, Kinzie MB, Farace E (2008) Caring for the brain tumor patient: family caregiver burden and unmet needs. Neuro-Oncology 10(1):61–72. doi:10.1215/15228517-2007-040 CrossRefPubMedPubMedCentral

35.

Seekatz B, Jentschke E, Lukasczik M, Neuderth S, Schuler M, van Oorschot B (2016) Identifikation nicht heilbarer Krebspatienten mit Palliativbedarf durch Screening [Identification of patients with incurable cancer and palliative care needs by screening]. Onkologe 22(11):870–877. doi:10.1007/s00761-016-0122-5 CrossRef

36.

Stenberg U, Ruland CM, Miaskowski C (2010) Review of the literature on the effects of caring for a patient with cancer. Psychooncology 19(10):1013–1025. doi:10.1002/pon.1670 CrossRefPubMed

37.

Stiel S, Matthes ME, Bertram L, Ostgathe C, Elsner F, Radbruch L (2010) Validierung der neuen Fassung des Minimalen Dokumentationssystems (MIDOS2) für Patienten in der Palliativmedizin [Validation of the new version of the minimal documentation system (MIDOS) for patients in palliative care: the German version of the Edmonton Symptom Assessment Scale (ESAS)]. Schmerz 24(6):596–604. doi:10.1007/s00482-010-0972-5 CrossRefPubMed

38.

Strittmatter G, Mawick R, Tilkorn M (2003) Hornheider Fragebogen. In: Schumacher J, Klaiberg A, Brähler E (eds) Diagnostische Verfahren zu Lebensqualität und Wohlbefinden. Hogrefe, Göttingen, pp 164–169

39.

Taphoorn MJ, Klein M (2004) Cognitive deficits in adult patients with brain tumours. Lancet Neurol 3(3):159–168. doi:10.1016/S1474-4422(04)00680-5 CrossRefPubMed

40.

Ullrich, J (2006) Belastung Angehöriger von onkologischen Patienten– Zur Validität des HFK-A. Diplomarbeit im Fach Psychologie, Christian-Albrechts-Universität Kiel

41.

Walbert T, Khan M (2014) End-of-life symptoms and care in patients with primary malignant brain tumors: a systematic literature review. J Neuro-Oncol 117(2):217–224. doi:10.1007/s11060-014-1393-6 CrossRef

42.

Zwahlen D, Hagenbuch N, Carley MI, Recklitis CJ, Buchi S (2008) Screening cancer patients’ families with the Distress Thermometer (DT): a validation study. Psychooncology 17(10):959–966. doi:10.1002/pon.1320 CrossRefPubMed

Title: Screening for symptom burden and supportive needs of patients with glioblastoma and brain metastases and their caregivers in relation to their use of specialized palliative care
Authors: Bettina Seekatz
Matthias Lukasczik
Mario Löhr
Katja Ehrmann
Michael Schuler
Almuth F. Keßler
Silke Neuderth
Ralf-Ingo Ernestus
Birgitt van Oorschot
Publication date: 01-09-2017
Publisher: Springer Berlin Heidelberg
Published in: Supportive Care in Cancer / Issue 9/2017
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-017-3687-7

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2017

Instruments to measure anxiety in children, adolescents, and young adults with cancer: a systematic review

Physiotherapy programme reduces fatigue in patients with advanced cancer receiving palliative care: randomized controlled trial

Voice rehabilitation after laryngeal cancer: Associated effects on psychological well-being

Erratum to: Prevalence and impact of severe fatigue in adolescent and young adult cancer patients in comparison with population-based controls

Effects of resistance exercise in prostate cancer patients: a meta-analysis

An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countries

Keynote webinar | Spotlight on antibody–drug conjugates in cancer